488 related articles for article (PubMed ID: 26687833)
1. Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.
Pizot C; Boniol M; Mullie P; Koechlin A; Boniol M; Boyle P; Autier P
Eur J Cancer; 2016 Jan; 52():138-54. PubMed ID: 26687833
[TBL] [Abstract][Full Text] [Related]
2. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
3. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618901
[TBL] [Abstract][Full Text] [Related]
4. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865
[TBL] [Abstract][Full Text] [Related]
5. Lifetime physical activity and the risk of breast cancer: a case-control study.
Kruk J
Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
Cerne JZ; Ferk P; Leskosek B; Gersak K
Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
Ayres de Campos D; Barros H; Martinez de Oliveira J
Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
[TBL] [Abstract][Full Text] [Related]
9. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
10. Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports.
Chen X; Wang Q; Zhang Y; Xie Q; Tan X
Value Health; 2019 Jan; 22(1):104-128. PubMed ID: 30661625
[TBL] [Abstract][Full Text] [Related]
11. Recent recreational physical activity and breast cancer risk in postmenopausal women in the E3N cohort.
Fournier A; Dos Santos G; Guillas G; Bertsch J; Duclos M; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1893-902. PubMed ID: 25114017
[TBL] [Abstract][Full Text] [Related]
12. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
[TBL] [Abstract][Full Text] [Related]
13. [Replacement therapy in menopause and risk for breast tumors].
Franceschi S
Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
16. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
17. Factors modifying the association between hormone-replacement therapy and breast cancer risk.
Pesch B; Ko Y; Brauch H; Hamann U; Harth V; Rabstein S; Pierl C; Fischer HP; Baisch C; Justenhoven C; Ranft U; Brüning T
Eur J Epidemiol; 2005; 20(8):699-711. PubMed ID: 16151884
[TBL] [Abstract][Full Text] [Related]
18. Adulthood lifetime physical activity and breast cancer.
Peplonska B; Lissowska J; Hartman TJ; Szeszenia-Dabrowska N; Blair A; Zatonski W; Sherman ME; Garcia-Closas M; Brinton LA
Epidemiology; 2008 Mar; 19(2):226-36. PubMed ID: 18277160
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
Tavani A; Braga C; La Vecchia C; Negri E; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):11-4. PubMed ID: 8993791
[TBL] [Abstract][Full Text] [Related]
20. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
